Skip to main content
Chemistry LibreTexts

Section 4 Final Evaluation

  • Page ID
    309940
  • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)

    ( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\id}{\mathrm{id}}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\kernel}{\mathrm{null}\,}\)

    \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\)

    \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\)

    \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    \( \newcommand{\vectorA}[1]{\vec{#1}}      % arrow\)

    \( \newcommand{\vectorAt}[1]{\vec{\text{#1}}}      % arrow\)

    \( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vectorC}[1]{\textbf{#1}} \)

    \( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)

    \( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)

    \( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)

    \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \(\newcommand{\avec}{\mathbf a}\) \(\newcommand{\bvec}{\mathbf b}\) \(\newcommand{\cvec}{\mathbf c}\) \(\newcommand{\dvec}{\mathbf d}\) \(\newcommand{\dtil}{\widetilde{\mathbf d}}\) \(\newcommand{\evec}{\mathbf e}\) \(\newcommand{\fvec}{\mathbf f}\) \(\newcommand{\nvec}{\mathbf n}\) \(\newcommand{\pvec}{\mathbf p}\) \(\newcommand{\qvec}{\mathbf q}\) \(\newcommand{\svec}{\mathbf s}\) \(\newcommand{\tvec}{\mathbf t}\) \(\newcommand{\uvec}{\mathbf u}\) \(\newcommand{\vvec}{\mathbf v}\) \(\newcommand{\wvec}{\mathbf w}\) \(\newcommand{\xvec}{\mathbf x}\) \(\newcommand{\yvec}{\mathbf y}\) \(\newcommand{\zvec}{\mathbf z}\) \(\newcommand{\rvec}{\mathbf r}\) \(\newcommand{\mvec}{\mathbf m}\) \(\newcommand{\zerovec}{\mathbf 0}\) \(\newcommand{\onevec}{\mathbf 1}\) \(\newcommand{\real}{\mathbb R}\) \(\newcommand{\twovec}[2]{\left[\begin{array}{r}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\ctwovec}[2]{\left[\begin{array}{c}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\threevec}[3]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\cthreevec}[3]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\fourvec}[4]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\cfourvec}[4]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\fivevec}[5]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\cfivevec}[5]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\mattwo}[4]{\left[\begin{array}{rr}#1 \amp #2 \\ #3 \amp #4 \\ \end{array}\right]}\) \(\newcommand{\laspan}[1]{\text{Span}\{#1\}}\) \(\newcommand{\bcal}{\cal B}\) \(\newcommand{\ccal}{\cal C}\) \(\newcommand{\scal}{\cal S}\) \(\newcommand{\wcal}{\cal W}\) \(\newcommand{\ecal}{\cal E}\) \(\newcommand{\coords}[2]{\left\{#1\right\}_{#2}}\) \(\newcommand{\gray}[1]{\color{gray}{#1}}\) \(\newcommand{\lgray}[1]{\color{lightgray}{#1}}\) \(\newcommand{\rank}{\operatorname{rank}}\) \(\newcommand{\row}{\text{Row}}\) \(\newcommand{\col}{\text{Col}}\) \(\renewcommand{\row}{\text{Row}}\) \(\newcommand{\nul}{\text{Nul}}\) \(\newcommand{\var}{\text{Var}}\) \(\newcommand{\corr}{\text{corr}}\) \(\newcommand{\len}[1]{\left|#1\right|}\) \(\newcommand{\bbar}{\overline{\bvec}}\) \(\newcommand{\bhat}{\widehat{\bvec}}\) \(\newcommand{\bperp}{\bvec^\perp}\) \(\newcommand{\xhat}{\widehat{\xvec}}\) \(\newcommand{\vhat}{\widehat{\vvec}}\) \(\newcommand{\uhat}{\widehat{\uvec}}\) \(\newcommand{\what}{\widehat{\wvec}}\) \(\newcommand{\Sighat}{\widehat{\Sigma}}\) \(\newcommand{\lt}{<}\) \(\newcommand{\gt}{>}\) \(\newcommand{\amp}{&}\) \(\definecolor{fillinmathshade}{gray}{0.9}\)

    1. In vitro to in vivo extrapolation (IVIVE) is modeling software that can utilize in vitro data and mathematically translate that into relevant in vivo information utilizing pharmacokinetic (PK).

    True

    False

    Answer

    True

    2. Which of the following is a common tool used for both Quantitative Structure Activity Relationships (QSAR) and Physiologically based pharmacokinetic (PBPK)?

    GastroPlus

    ADMET Predictor

    ACD Toxsuite

    Derek

    Answer

    GastroPlus

    3. HumanOmni 5 Quad (Omni 5), illumina Omni Arrays and the Affymetrix platforms are common methods used in:

    Transcriptomics

    Genomics

    Proteomics

    Metabolomics

    Answer

    Genomics

    4. Quantitative Structure Activity Relationships (QSAR) approaches for predictive toxicity testing requires all the following EXCEPT:

    Lots of data in order to build robust databases.

    Validation of QSAR relationships with large sets of in vitro and in vivo datasets.

    Extensive collaboration between scientists across different disciplines of toxicology.

    A mass spectrophotometer.

    Answer

    A mass spectrophotometer.

    5. Computational modeling tools utilizes the in vitro data and integrate them into human physiology with the help of...

    Physiologically based pharmacokinetic model.

    High-throughput in vitro model.

    Hypothesis and diagnostic model.

    Mathematical and computational model.

    Answer

    Physiologically based pharmacokinetic model.

    6. Systems toxicology aims to fill this gap and utilize these data from different systems and integrate them into meaningful assessment for safety. This gap is:

    Lack of modern equipment and technology for data collection.

    Lack of interpretation and utilization of collected data.

    Lack of human resources and management.

    Lack of organ and system models.

    Answer

    Lack of interpretation and utilization of collected data.

    7. Adverse Output Pathways (AOP) can be assessed in the following stages:

    Molecular initiating event

    Intermediate response at cellular level

    Toxic response at organic level

    All of the above

    Answer

    All of the above

    8. In Metabolomics, the major difference between liquid chromatography mass spectrometers (LCMS) and nuclear magnetic resonance (NMS) is...

    NMR samples cannot be reused for other purposes while LCMS samples can be reused for other purposes.

    NMR is a destructive process whereas LCMS is a non-destructive process.

    NMR is a non-destructive process whereas LCMS is a destructive process.

    NMR samples cannot be returned to the biorepository whereas LCMS samples can be returned to the biorepository.

    Answer

    NMR is a non-destructive process whereas LCMS is a destructive process.

    9. In the study of the underlying mechanisms of different diseases at the genomic level, the most common form of variants at this level is:

    Polyploidy

    Aneuploidy

    Single Nucleotide Polymorphism (SNP)

    Micronuclei variants

    Answer

    Single Nucleotide Polymorphism (SNP)

    10. ____ is used for analysis of proteomics data:

    A mass spectrophotometer

    DNA micro array

    Illumni Omni Array

    DNA sequencing

    Answer

    A mass spectrophotometer

    11. The ToxCast program utilizes which kind of assays?

    In vivo

    In vitro

    In silico

    All of the above

    Answer

    In vitro

    12. The following agencies were established to address the challenge of large number of chemicals that go to market with very limited or no toxicity testing:

    Environmental Protection Agency (EPA) in the US.

    Registration Evaluation Authorization and Restriction of Chemicals (REACH) in Europe.

    Both A & B are correct.

    Occupational Safety and Health Administration (OSHA).

    Answer

    Both A & B are correct.


    This page titled Section 4 Final Evaluation is shared under a CC BY-NC 4.0 license and was authored, remixed, and/or curated by ToxMSDT Online component via source content that was edited to the style and standards of the LibreTexts platform.

    • Was this article helpful?